App-Quantinova.ai

Recurrent Acute Ischemic Stroke in a Child on Novalung iLA Treated Twice With Mechanical Clot Retrieval: a Case Report and Review of the Literature

Maria C Buompadre - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Understanding the Clinician- Experiences in Collecting Stroke Rehabilitation Intensity Data Within Ontario

Elizabeth Linkewich - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Comparing Risk of Stroke and Death in Treated and Untreated Patients With Unruptured Brain Arteriovenous Malformations (BAVM)

Jeffrey Nelson - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Adiponectin Stimulates Cholesterol Efflux Efficiently in Human THP-1 Macrophages and Modulates HDL-apoA-I Biogenesis

Anouar Hafiane - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Stimulation of Angiogenesis and the Generation of New Cardiomyocytes Underlie Therapeutic Regeneration by Encapsulated Explant-Derived Cardiac Stem Cells in Advanced Ischemic Cardiomyopathy

Pushpinder Kanda - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

N/A

Safety and Outcome of High Doses IV Milirinone in Subarachnoid Hemorrhage With Refractory Vasospasm

Abdulrahman Alturki - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

Milrinone

Infantile Spasms After Early Pediatric Arterial Ischemic Stroke.

Morris Scantlebury - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

Vigabatrin

Endovascular Treatment of Severe and Refractory Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Improves Outcome: A Systematic Review and Meta-analysis of Different Treatment Options Evaluated Since 2006 for Cerebral Vasospasm

Marc-Antoine Labeyrie - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subarachnoid hemorrhage

cilostazol

Detecting Diseased Tissue in Normal Appearing White Matter of Transient Ischemic Attack and Minor Stroke Patients Using Texture Analysis

Stephen Campeau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

Quantitative Assessment of Cerebrovascular Reactivity in Paediatric Moyamoya

Derek Armstrong - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Moyamoya Disease

N/A

Arterial Tortuosity: an Imaging Biomarker of Perinatal Stroke Pathogenesis?

Karl Diedrich - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arterial tortuosity syndrome

N/A

Epilepsy is Associated With Poorer Neurologic Outcome After Pediatric Arterial Ischemic Stroke

Lori C. Jordan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Pre-stroke Antithrombotic Therapy and Stroke Severity in Acute Ischemic Stroke Patients With Atrial Fibrillation

Emily C O'Brien - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Clopidogrel bisulfate

The Separation of Serum Amyloid A from HDL is Mediated by Heparan Sulfate Through Histidine Dependent Interactions: HDL Function is Enhanced but Amyloid-Fibrils may be the Price to Pay?

John B Ancsin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

Heparin

Patient, Cardiac Arrest and Hospital Characteristics That Predict Receipt of Coronary Angiography in Out-of-hospital Cardiac Arrest Patients

Steven Brooks - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

How Often Should Chest Compressions be Paused to Assess the Cardiac Rhythm? A Systematic Review and Meta-analysis

Violetta Raffay - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Microsomal Triglyceride Transfer Protein Is a Major Determinant of Plasma Ceramide And Sphingomyelin but Not of Hexosylceramide and Lactosylceramide

Meghan T Walsh - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Abetalipoproteinemia

N/A

Restoration of ER Stress and Induction of FGF15/19 Independently Rescue ABCG5 ABCG8 Sterol Transporter

Kai Su - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Characterization of the Immune Response to Aortic Aneurysm in a Murine Model

Rickvinder Besla - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Aortic dilatation

Angiotensin II

Development of a New Bioactivatable Fluorescent Probe for the Study of the Proteolytic Activities Degrading Apolipoprotein A-I in vitro and in vivo

Baoqiang Li - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Cysteine Hydrochloride

Filters

28841 Abstracts